N. Colombo

7.2k total citations · 4 hit papers
63 papers, 5.0k citations indexed

About

N. Colombo is a scholar working on Oncology, Reproductive Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N. Colombo has authored 63 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Reproductive Medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N. Colombo's work include Ovarian cancer diagnosis and treatment (21 papers), Chemotherapy-induced cardiotoxicity and mitigation (11 papers) and Endometrial and Cervical Cancer Treatments (7 papers). N. Colombo is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Chemotherapy-induced cardiotoxicity and mitigation (11 papers) and Endometrial and Cervical Cancer Treatments (7 papers). N. Colombo collaborates with scholars based in Italy, United States and Spain. N. Colombo's co-authors include Daniela Cardinale, Carlo M. Cipolla, Maurizio Civelli, Alessandro Colombo, Giuseppina Lamantia, Cesare Fiorentini, Fabrizio Veglia, Maria Teresa Sandri, Giovanni Martinelli and Ines Tedeschi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

N. Colombo

61 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

2015 1.1k citations Daniela Cardinale, Alessandro Colombo et al. profile →
Anthracycline-Induced Cardiomyopathy

2010 772 citations Daniela Cardinale, Alessandro Colombo et al. Journal of the American College of Cardiology profile →
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

2006 706 citations Daniela Cardinale, Alessandro Colombo et al. profile →
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy

2004 659 citations Daniela Cardinale, Maria Teresa Sandri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Colombo Italy	21	3.7k	2.3k	1.1k	863	466	63	5.0k
Thomas Suter Switzerland	34	2.9k 0.8×	2.2k 1.0×	865 0.8×	564 0.7×	764 1.6×	78	4.4k
James L. Speyer United States	37	1.2k 0.3×	2.2k 1.0×	363 0.3×	788 0.9×	928 2.0×	94	4.4k
Peter Canney United Kingdom	25	599 0.2×	1.3k 0.6×	397 0.4×	472 0.5×	359 0.8×	77	2.6k
Irene Kuter United States	24	1.6k 0.4×	3.4k 1.5×	1.3k 1.3×	1.5k 1.7×	513 1.1×	45	5.3k
Rosalba Torrisi Italy	35	429 0.1×	2.4k 1.0×	483 0.5×	671 0.8×	1.0k 2.2×	130	4.2k
Michael S. Ewer United States	25	1.7k 0.5×	3.4k 1.5×	991 0.9×	752 0.9×	453 1.0×	62	4.6k
Priya Rastogi United States	34	486 0.1×	4.8k 2.1×	1.2k 1.2×	1.4k 1.6×	1.1k 2.4×	142	6.7k
Marc Espié France	46	257 0.1×	3.0k 1.3×	1.9k 1.8×	942 1.1×	983 2.1×	180	5.8k
Gilles Romieu France	37	247 0.1×	4.8k 2.1×	873 0.8×	2.1k 2.4×	1.2k 2.6×	136	6.2k
Mark Verrill United Kingdom	23	705 0.2×	1.3k 0.6×	313 0.3×	648 0.8×	409 0.9×	85	2.4k

Countries citing papers authored by N. Colombo

Since Specialization

Citations

This map shows the geographic impact of N. Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Colombo more than expected).

Fields of papers citing papers by N. Colombo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Colombo. The network helps show where N. Colombo may publish in the future.

Co-authorship network of co-authors of N. Colombo

This figure shows the co-authorship network connecting the top 25 collaborators of N. Colombo. A scholar is included among the top collaborators of N. Colombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Colombo. N. Colombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodrigues, Manuel, Adrien Briaux, Éric Pujade-Lauraine, et al.. (2023). 38MO Validation study of the ShallowHRDv2 assay for homologous recombination deficiency (HRD) detection in high-grade ovarian carcinomas (HGOC) in the first-line setting, from the phase III PAOLA-1/ENGOT-ov25 trial. ESMO Open. 8(1). 100818–100818. 3 indexed citations

Matulonis, U., Katherine Moore, Domenica Lorusso, et al.. (2022). 592P Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer. Annals of Oncology. 33. S817–S817. 2 indexed citations

Colombo, N., Dorothy Nguyen, Gini F. Fleming, et al.. (2021). 721O Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study. Annals of Oncology. 32. S725–S725. 12 indexed citations

Lazzari, Roberta, Viviana Galimberti, E. Rondi, et al.. (2018). Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED). Breast Cancer Research and Treatment. 171(3). 693–699. 2 indexed citations

Cardinale, Daniela, Maria Teresa Sandri, Alessandro Colombo, et al.. (2016). Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery. Annals of Surgery. 264(2). 244–251. 43 indexed citations

Cipolla, Carlo M., Alessandro Colombo, Rosalba Torrisi, et al.. (2010). CLINICAL AND PROGNOSTIC IMPLICATIONS OF EARLY TROPONIN I INCREASE IN TRASTUZUMAB INDUCED CARDIOTOXICITY.. Journal of the American College of Cardiology. 55(10). A34.E332–A34.E332. 1 indexed citations

Gentilini, Oreste, Marta Cremonesi, Antonio Toesca, et al.. (2009). Sentinel lymph node biopsy in pregnant patients with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 37(1). 78–83. 74 indexed citations

Colombo, N.. (2009). Long QT syndrome and torsade de pointes after anthracycline chemotherapy. ecancermedicalscience. 3. 147–147. 4 indexed citations

Colombo, N., Giorgia Mangili, Serafina Mammoliti, et al.. (2008). Aflibercept (VEGF Trap) for advanced epithelial ovarian cancer (EOC) patients (pts) with symptomatic malignant ascites: Preliminary results of a pilot study. Journal of Clinical Oncology. 26(15_suppl). 14598–14598. 19 indexed citations

10.

Cardinale, Daniela, Alessandro Colombo, & N. Colombo. (2006). Acute coronary syndrome induced by oral capecitabine. Canadian Journal of Cardiology. 22(3). 251–253. 27 indexed citations

11.

Civelli, Maurizio, Daniela Cardinale, Alessandro Martinoni, et al.. (2005). Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity. International Journal of Cardiology. 111(1). 120–126. 59 indexed citations

12.

Ledermann, JA, N. Colombo, Andreas du Bois, et al.. (2003). Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003). UCL Discovery (University College London). 2 indexed citations

13.

Wagenaar, Hendrik, N. Colombo, Ignace Vergote, et al.. (2001). Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study. Gynecologic Oncology. 81(3). 348–354. 57 indexed citations

14.

Floriani, Irene, Alessandro Buda, Maria Grazia Cantù, et al.. (2000). Randomised trial comparing doxorubicin, paclitaxel (AT), versus paclitaxel (T), as second line therapy for advanced ovarian cancer (AOC) patients in early progression after platinum-based chemotherapy.. Annals of Oncology. 11. 32–32. 5 indexed citations

15.

Colombo, N., Gabriella Parma, Luca Bocciolone, et al.. (2000). Medical therapy of advanced malignant epithelial tumours of the ovary. The Forum. 10(4). 323–332. 5 indexed citations

16.

Cicco, Concetta De, Mario Sideri, Mirco Bartolomei, et al.. (2000). Sentinel node biopsy in early vulvar cancer. British Journal of Cancer. 82(2). 295–299. 126 indexed citations

17.

Pazzucconi, Franco, et al.. (1996). Iron-ovotransferrin preparation does not interfere with ciprofloxacin absorption*. Clinical Pharmacology & Therapeutics. 59(4). 418–422. 5 indexed citations

18.

Tagliabue, Elda, Manuela Campiglio, Sylvie Ménard, et al.. (1993). Overexpression of p185 is not related to erbB2 amplification in ovarian cancer. Annals of Oncology. 4(9). 775–779. 6 indexed citations

19.

Colombo, N., C. Sessa, Fabio Landoni, et al.. (1986). Cisplatin, Vinblastine, and Bleomycin Combination Chemotherapy in Metastatic Granulosa Cell Tumor of the Ovary. Obstetrics and Gynecology. 67(2). 265–268. 82 indexed citations

20.

Morasca, L., Eugenio Erba, Massimo Vaghi, et al.. (1984). In vitro cytotoxicity of VP-16213 on human ovarian cancer.. Journal of Experimental & Clinical Cancer Research. 3(3). 305–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact